Human Bone Marrow-derived Clonal Mesenchymal Stem Cells Decrease the Initial C-Reactive Protein Level in Patients With Moderately Severe to Severe Acute Pancreatitis

Gastroenterology. 2023 Jun;164(7):1317-1320.e2. doi: 10.1053/j.gastro.2023.02.009. Epub 2023 Feb 18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Acute Disease
  • Bone Marrow
  • Bone Marrow Cells / metabolism
  • C-Reactive Protein / metabolism
  • Humans
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells* / metabolism
  • Pancreatitis* / metabolism
  • Pancreatitis* / therapy

Substances

  • C-Reactive Protein